Home‎ > ‎

Works Cited

Works Cited

[1] D Abeck. Rationale of frequency of use of ciclopirox 1 treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage. Int J Dermatol, 43 Suppl 1:13-16, Jul 2004.
[2] N N Abou-Mourad, F S Farah, and D Steel. Dermopathic changes in hypozincemia. Arch Dermatology, 115(8):956-958, Aug 1979.
[3] N S Al-Waili. Therapeutic and prophylactic effects of crude honey on chronic seborrheic dermatitis and dandruff. Eur J Med Res, 6(7):306-308, Jul 2001.
[4] P Altmeyer and K Hoffmann. Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial. Int J Dermatol, 43 Suppl 1:9-12, Jul 2004.
[5] H R Ashbee, E Ingham, K T Holland, and W J Cunliffe. The carriage of malassezia furfur serovars a, b and c in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Br J Dermatol, 129(5):533-540, Nov 1993.
[6] H R Ashbee, A Fruin, K T Holland, W J Cunliffe, and E Ingham. Humoral immunity to malassezia furfur serovars a, b and c in patients with pityriasis versicolor, seborrheic dermatitis and controls. Exp Dermatol, 3(5):227-233, Oct 1994.
[7] H R Ashbee, E Ingham, K T Holland, and W J Cunliffe. Cell-mediated immune responses to malassezia furfur serovars a, b and c in patients with pityriasis versicolor, seborrheic dermatitis and controls. Exp Dermatol, 3(3):106-112, Jun 1994.
[8] O Bayrou, C Pecquet, A Flahault, C Artigou, N Abuaf, and F Leynadier. Head and neck atopic dermatitis and malassezia-furfur-specific ige antibodies. Dermatology, 211(2):107-113, 2005.
[9] V Baysal, M Yildirim, C Ozcanli, and A M Ceyhan. Itraconazole in the treatment of seborrheic dermatitis: a new treatment modality. Int J Dermatol, 43(1):63-66, Jan 2004.
[10] I M Bergbrant. Seborrhoeic dermatitis and pityrosporum ovale: cultural, immunological and clinical studies. Acta Derm Venereol Suppl (Stockh), 167:1-36, 1991.
[11] I M Bergbrant. Seborrhoeic dermatitis and pityrosporum yeasts. Curr Top Med Mycol, 6:95-112, 1995.
[12] I M Bergbrant, B Andersson, and J Faergemann. Cell-mediated immunity to malassezia furfur in patients with seborrhoeic dermatitis and pityriasis versicolor. Clin Exp Dermatol, 24(5):402-406, Sep 1999.
[13] T J Braza, J B DiCarlo, S L Soon, and C O McCall. Tacrolimus 0.1 pilot study. Br J Dermatol, 148(6):1242-1244, Jun 2003.
[14] I Brownell, L T Quan, and S Hsu. Topical pimecrolimus in the treatment of seborrheic dermatitis. Dermatol Online J, 9(3):13-13, Aug 2003.
[15] R Caputo. Itraconazole (sporanox) in superficial and systemic fungal infections. Expert Rev Anti Infect Ther, 1(4):531-542, Dec 2003.
[16] T Cokun, A Tokatli, and I Ozalp. Inborn errors of biotin metabolism. clinical and laboratory features of eight cases. Turk J Pediatr, 36(4):267-278, Oct-Dec 1994.
[17] N C Cowley, P M Farr, and S Shuster. The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol, 122(1):71-76, Jan 1990.
[18] N C Cowley and P M Farr. A dose-response study of irritant reactions to sodium lauryl sulphate in patients with seborrhoeic dermatitis and atopic eczema. Acta Derm Venereol, 72(6):432-435, Nov 1992.
[19] C Cuelenaere, J De Bersaques, and A Kint. Use of topical lithium succinate in the treatment of seborrhoeic dermatitis. Dermatology, 184(3):194-197, 1992.
[20] F W Danby, W S Maddin, L J Margesson, and D Rosenthal. A randomized, double-blind, placebo-controlled trial of ketoconazole 2 to severe dandruff. J Am Acad Dermatol, 29(6):1008-1012, Dec 1993.
[21] Y M DeAngelis, C M Gemmer, J R Kaczvinsky, D C Kenneally, J R Schwartz, and T L Dawson. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J Investig Dermatol Symp Proc, 10(3):295-297, Dec 2005.
[22] D T Downing, M E Stewart, and J S Strauss. Changes in sebum secretion and the sebaceous gland. Clin Geriatr Med, 5(1):109-114, Feb 1989.
[23] B Dreno and D Moyse. Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double-blind study versus placebo. Eur J Dermatol, 12(6):549-552, Nov-Dec 2002.
[24] B Dreno, O Chosidow, J Revuz, and D Moyse. Lithium gluconate 8 seborrhoeic dermatitis: a multicentre, randomized study. Br J Dermatol, 148(6):1230-1236, Jun 2003.
[25] E Drouhet, D Dompmartin, A Papachristou-Moraiti, and P Ravisse. [experimental dermatitis caused by pityrosporum ovale and (or) pityrosporum orbiculare in the guinea pig and the mouse]. Sabouraudia, 18(2):149-156, Jun 1980.
[26] J Faergemann. Short-term treatment of dandruff with a combination of propylene glycol solution and shampoo. Cutis, 42(2):146-146, Aug 1988.
[27] J Faergemann. Propylene glycol in the treatment of seborrheic dermatitis of the scalp: a double-blind study. Cutis, 42(1):69-71, Jul 1988.
[28] J Faergemann. Treatment of seborrhoeic dermatitis with bifonazole. Mycoses, 32(6):309-311, Jun 1989.
[29] J Faergemann. Pityrosporum yeasts-what's new? Mycoses, 40 Suppl 1:29-32, 1997.
[30] C Ferrndiz, J Henkes, J Peyr, and J Sarmiento. Acquired zinc deficiency syndrome during total parenteral alimentation. clinical and histopathological findings. Dermatologica, 163(3):255-266, 1981.
[31] A Firooz, A Solhpour, F Gorouhi, M Daneshpazhooh, K Balighi, K Farsinejad, M Rashighi-Firoozabadi, and Y Dowlati. Pimecrolimus cream, 1 treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial. Arch Dermatol, 142(8):1066-1067, Aug 2006.
[32] S Freeman, A Howard, P Foley, R Rosen, G Wood, J A See, and S Gray. Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05 atopic or seborrhoeic dermatitis. Australas J Dermatol, 43(3):186-189, Aug 2002.
[33] J Fuchs. [vitamins and skin]. Ther Umsch, 51(7):489-495, Jul 1994.
[34] T Gambichler, F Breuckmann, S Boms, P Altmeyer, and A Kreuter. Narrowband uvb phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol, 52(4):660-670, Apr 2005.
[35] S E Geissler, S Michelsen, and G Plewig. Very low dose isotretinoin is effective in controlling seborrhea. J Dtsch Dermatol Ges, 1(12):952-958, Dec 2003.
[36] Beth Gilbert. Paradigm shift in rosacea. Dermatology Times <http://dermatologytimes.com/dermatologytimes/article/articleDetail.jsp?id=157799>, March 2005.
[37] P Gisondi, C N Ellis, and G Girolomoni. Pimecrolimus in dermatology: atopic dermatitis and beyond. Int J Clin Pract, 59(8):969-974, Aug 2005.
[38] A K Gupta and R Bluhm. Itraconazole (sporanox) for seborrheic dermatitis. Skin Therapy Lett, 7 Suppl 1:4-8, 2002.
[39] A K Gupta, R Bluhm, E A Cooper, R C Summerbell, and R Batra. Seborrheic dermatitis. Dermatol Clin, 21(3):401-412, Jul 2003.
[40] A K Gupta, K Nicol, and R Batra. Role of antifungal agents in the treatment of seborrheic dermatitis. Am J Clin Dermatol, 5(6):417-422, 2004.
[41] A K Gupta and K Nicol. The use of sulfur in dermatology. J Drugs Dermatol, 3(4):427-431, Jul-Aug 2004.
[42] A K Gupta and R Bluhm. Seborrheic dermatitis. J Eur Acad Dermatol Venereol, 18(1):13-26, Jan 2004.
[43] A K Gupta and R Bluhm. Ciclopirox (loprox) gel for superficial fungal infections. Skin Therapy Lett, 9(7):4-5, Aug-Sep 2004.
[44] A K Gupta and R Bluhm. Ciclopirox shampoo for treating seborrheic dermatitis. Skin Therapy Lett, 9(6):4-5, Jun-Jul 2004.
[45] A K Gupta and K A Nicol. Ciclopirox 1 Int J Dermatol, 45(1):66-69, Jan 2006.
[46] Dr. Hazy. Principles of pediatric dermatology - chapter 27. <http://www.dermatologyinfo.net/english/chapters/chapter27.htm>, 21 December 2006.
[47] M C Heng, C L Henderson, D C Barker, and G Haberfelde. Correlation of pityosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique. J Am Acad Dermatol, 23(1):82-86, Jul 1990.
[48] A Herrera-Arellano, E Jiménez-Ferrer, A M Vega-Pimentel, M d e L Martínez-Rivera, M Hernández-Hernández, A Zamilpa, and J Tortoriello. Clinical and mycological evaluation of therapeutic effectiveness of solanum chrysotrichum standardized extract on patients with pityriasis capitis (dandruff). a double blind and randomized clinical trial controlled with ketoconazole. Planta Med, 70(6):483-488, Jun 2004.
[49] W A High and A G Pandya. Pilot trial of 1 dermatitis in african american adults with associated hypopigmentation. J Am Acad Dermatol, 54(6):1083-1088, Jun 2006.
[50] T B Kantardjiev, L G Zisova, and A H Kuzmanov. Study of the titer of common antibodies against superficial antigens of pityrosporum ovale in dermatitis seborrhoides. Folia Med (Plovdiv), 43(3):37-40, 2001.
[51] M Kieffer, I M Bergbrant, J Faergemann, G B Jemec, V Ottevanger, P Stahl Skov, and E Svejgaard. Immune reactions to pityrosporum ovale in adult patients with atopic and seborrheic dermatitis. J Am Acad Dermatol, 22(5 Pt 1):739-742, May 1990.
[52] O Kose, H Erbil, and A R Gur. Oral itraconazole for the treatment of seborrhoeic dermatitis: an open, noncomparative trial. J Eur Acad Dermatol Venereol, 19(2):172-175, Mar 2005.
[53] Kostovia K and Lipozenciz. Skin diseases in alcoholics. Acta Dermatovenerol Croat, 12(3):181-190, 2004.
[54] J A Langtry, C M Rowland Payne, R C Staughton, J C Stewart, and D F Horrobin. Topical lithium succinate ointment (efalith) in the treatment of aids-related seborrhoeic dermatitis. Clin Exp Dermatol, 22(5):216-219, Sep 1997.
[55] S Lautenschlager and A Eichmann. [skin changes in hiv infections]. Ther Umsch, 52(4):275-281, Apr 1995.
[56] C Lidn and J E Wahlberg. Work with video display terminals among office employees. v. dermatologic factors. Scand J Work Environ Health, 11(6):489-493, Dec 1985.
[57] G Maietta, P Fornaro, F Rongioletti, and A Rebora. Patients with mood depression have a high prevalence of seborrhoeic dermatitis. Acta Derm Venereol, 70(5):432-434, 1990.
[58] G Maietta, F Rongioletti, and A Rebora. Seborrheic dermatitis and daylight. Acta Derm Venereol, 71(6):538-539, 1991.
[59] C T Marino, E McDonald, and J F Romano. Seborrheic dermatitis in acquired immunodeficiency syndrome. Cutis, 48(3):217-218, Sep 1991.
[60] A Meshkinpour, J Sun, and G Weinstein. An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol, 49(1):145-147, Jul 2003.
[61] S H Mirza, H Rehman, and M A Khan. Role of malassezia yeast (pityrosporum) in seborrhoeic dermatitis (sd). J Coll Physicians Surg Pak, 15(12):771-773, Dec 2005.
[62] M Moehrle, B Dennenmoser, B Schlagenhauff, S Thomma, and C Garbe. High prevalence of seborrhoeic dermatitis on the face and scalp in mountain guides. Dermatology, 201(2):146-147, 2000.
[63] L L Molinero, M Gruber, J Leoni, A Woscoff, and N W Zwirner. Up-regulated expression of mica and proinflammatory cytokines in skin biopsies from patients with seborrhoeic dermatitis. Clin Immunol, 106(1):50-54, Jan 2003.
[64] E D Montero, A Arevalo, and M Michelotti. [anti-androgens. their use in dermatology]. Med Cutan Ibero Lat Am, 9(4):275-284, 1981.
[65] P Nenoff, U F Haustein, and A Fiedler. The antifungal activity of a coal tar gel on malassezia furfur in vitro. Dermatology, 191(4):311-314, 1995.
[66] P Nenoff, U F Haustein, and W Brandt. Antifungal activity of the essential oil of melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacol, 9(6):388-394, 1996.
[67] L C Parish and E Fine. Alcoholism and skin disease. Int J Dermatol, 24(5):300-301, Jun 1985.
[68] M E Parry and G R Sharpe. Seborrhoeic dermatitis is not caused by an altered immune response to malassezia yeast. Br J Dermatol, 139(2):254-263, Aug 1998.
[69] S Passi, A Morrone, C De Luca, M Picardo, and F Ippolito. Blood levels of vitamin e, polyunsaturated fatty acids of phospholipids, lipoperoxides and glutathione peroxidase in patients affected with seborrheic dermatitis. J Dermatol Sci, 2(3):171-178, May 1991.
[70] M Pechere, J Krischer, C Remondat, C Bertrand, L Trellu, and J H Saurat. Malassezia spp carriage in patients with seborrheic dermatitis. J Dermatol, 26(9):558-561, Sep 1999.
[71] C Piérard-Franchimont, G E Piérard, J E Arrese, and P De Doncker. Effect of ketoconazole 1 seborrhoeic dermatitis: clinical, squamometric and mycological assessments. Dermatology, 202(2):171-176, 2001.
[72] C Piérard-Franchimont, V Goffin, J Decroix, and G E Piérard. A multicenter randomized trial of ketoconazole 2 1 Skin Pharmacol Appl Skin Physiol, 15(6):434-441, Nov-Dec 2002.
[73] A Ranki, P Puska, S Mattinen, A Lagerstedt, and K Krohn. Effect of puva on immunologic and virologic findings in hiv-infected patients. J Am Acad Dermatol, 24(3):404-410, Mar 1991.
[74] B I Ro and T L Dawson. The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff. J Investig Dermatol Symp Proc, 10(3):194-197, Dec 2005.
[75] A C Satchell, A Saurajen, C Bell, and R S Barnetson. Treatment of dandruff with 5 J Am Acad Dermatol, 47(6):852-855, Dec 2002.
[76] R C Schechtman, G Midgley, and R J Hay. Hiv disease and malassezia yeasts: a quantitative study of patients presenting with seborrhoeic dermatitis. Br J Dermatol, 133(5):694-698, Nov 1995.
[77] K H Schulpis, J O Nyalala, E D Papakonstantinou, L Leondiadis, E Livaniou, D Ithakisios, and S Georgala. Biotin recycling impairment in phenylketonuric children with seborrheic dermatitis. Int J Dermatol, 37(12):918-921, Dec 1998.
[78] K H Schulpis, S Georgala, E D Papakonstantinou, T Michas, and G A Karikas. The effect of isotretinoin on biotinidase activity. Skin Pharmacol Appl Skin Physiol, 12(1-2):28-33, Jan-Apr 1999.
[79] R Segal, M David, A Ingber, R Lurie, and M Sandbank. Treatment with bifonazole shampoo for seborrhea and seborrheic dermatitis: a randomized, double-blind study. Acta Derm Venereol, 72(6):454-455, Nov 1992.
[80] O J Stone. Pyridoxine deficiency and antagonism produce increased ground substance viscosity with resulting seborrheic dermatitis and increased tumor resistance. Med Hypotheses, 30(4):277-280, Dec 1989.
[81] Linda Sy. [rosacea] re: ? for dr. sy. <rosacea-support@groups.yahoo.com>, 2 April 1999.
[82] G A Vena, G Micali, P Santoianni, N Cassano, and E Peruzzi. Oral terbinafine in the treatment of multi-site seborrhoic dermatitis: a multicenter, double-blind placebo-controlled study. Int J Immunopathol Pharmacol, 18(4):745-753, Oct-Dec 2005.
[83] R A Vignale, E Civila, E Lasalvia, and J Paciel. [in vitro blastogenic response of lymphocytes in pityriasis capitis and dermatitis seborrheica (using pha-mitogen, pityrosporum ovale and bacteria)]. Med Cutan Ibero Lat Am, 9(1):41-44, 1981.
[84] R Vijayakumar, C Muthukumar, T Kumar, and R Saravanamuthu. Characterization of malassezia furfur and its control using plant extracts. Indian Journal of Dermatology, 51(2):145-148, 2006.
[85] I Wegrzynek and E Budzanowska. [alcohol and the skin]. Przegl Lek, 58(4):198-203, 2001.
[86] W Wigger-Alberti, K Kluge, and P Elsner. [clinical effectiveness and tolerance of climbazole containing dandruff shampoo in patients with seborrheic scalp eczema]. Schweiz Rundsch Med Prax, 90(33):1346-1349, Aug 2001.
[87] J R Wikler, N Janssen, D P Bruynzeel, and C Nieboer. The effect of uv-light on pityrosporum yeasts: ultrastructural changes and inhibition of growth. Acta Derm Venereol, 70(1):69-71, 1990.
[88] N Wonglikhitpanya and S Taneepanichskul. Effects of biphasic oral contraceptives containing desogestrel (oilezz) on cycle control facial acne and seborrhea in healthy thai women. J Med Assoc Thai, 89(6):755-760, Jun 2006.
[89] Z Zaidi, Z Wahid, R Cochinwala, M Soomro, and A Qureishi. Correlation of the density of yeast malassezia with the clinical severity of seborrhoeic dermatitis. J Pak Med Assoc, 52(11):504-506, Nov 2002.
[90] A Zeharia, M Mimouni, and D Fogel. Treatment with bifonazole shampoo for scalp seborrhea in infants and young children. Pediatr Dermatol, 13(2):151-153, Mar-Apr 1996.
[91] HP Ammon, H. Safayhi, T. Mack, and J. Sabieraj. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol, 38(2-3):113-9, 1993.
[92] Tony Baker. Glycerin may help skin disease, study finds. <http://www.mcg.edu/news/2003NewsRel/glycerin.html>, 21 December 2003.
[93] N. Banno, T. Akihisa, K. Yasukawa, H. Tokuda, K. Tabata, Y. Nakamura, R. Nishimura, Y. Kimura, and T. Suzuki. Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri. J Ethnopharmacol, 2006.
[94] GP Benetti, L. Fugazza, M. Stramba Badiale, F. Montalto, G. Bombelli, G. La Vecchia, MT Illeni, and C. Uslenghi. Ex vivo evaluation of pidotimod activity on cell-mediated immunity. Arzneimittelforschung, 44(12A):1476-9, 1994.
[95] JM Bonnetblanc and P. Bernard. Benzoyl peroxide in seborrheic dermatitis. Arch Dermatol, 122(7):752, 1986.
[96] M. Buslau, H. Hanel, and H. Holzmann. The significance of yeasts in seborrheic eczema. Hautarzt, 40(10):611-3, 1989.
[97] PG Calzavara-Pinton, M. Venturini, and R. Sala. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobiol B, 78(1):1-6, 2005.
[98] A.J. Carrillo-Muñoz, G. Giusiano, P.A. Ezkurra, and G. Quindós. Sertaconazole: updated review of a topical antifungal agent. Expert Rev. Anti Infect. Ther, 3(3):333-342, 2005.
[99] M.I. Duque, C.A. Vogel, A.B. Fleischer, and G. Yosipovitch. Over-the-counter topical antipruritic agents are commonly recommended by office-based physicians: an analysis of US practice patterns. Journal of Dermatological Treatment, 15(3):185-188, 2004.
[100] David Ellis. Fungal descriptions - malassezia yeast. <http://www.mycology.adelaide.edu.au/Fungal_Descriptions/Yeasts/Malassezia/>, July 2006.
[101] B.B. Eriksen and D.L. Kåre. Open trial of supplements of omega 3 and 6 fatty acids, vitamins and minerals in atopic dermatitis. Journal of Dermatological Treatment, 17(2):82-85, 2006.
[102] J. Faergemann. Pityrosporum species as a cause of allergy and infection. Allergy, 54(5):413-419, 1999.
[103] J. Faergemann. Management of Seborrheic Dermatitis and Pityriasis Versicolor. Am J Clin Dermatol, 1(2):75-80, 2000.
[104] JJ Grob, M. Castelain, MA Richard, JP Bonniol, V. Beraud, H. Adhoute, N. Guillou, and JJ Bonerandi. Antiinflammatory properties of cetirizine in a human contact dermatitis model. Clinical evaluation of patch tests is not hampered by antihistamines. Acta Derm Venereol, 78(3):194-7, 1998.
[105] A.K. Gupta, J.E. Ryder, K. Nicol, and E.A. Cooper. Superficial fungal infections: an update on pityriasis versicolor, seborrheic dermatitis, tinea capitis, and onychomycosis. Clinics in Dermatology, 21(5):417-425, 2003.
[106] S. HELLAND, K.M.T.S. ODU, ES FALK, and K. SOLVOLL. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind^ multicentre study. British Journal of Dermatology, 130:757-764, 1994.
[107] E.A. Holm and G.B.E. Jemec. The therapeutic potential of calcipotriol in diseases other than psoriasis. International Journal of Dermatology, 41(1):38-43, 2002.
[108] B.A. Johnson and J.R. Nunley. Treatment of seborrheic dermatitis. Am Fam Physician, 61(9):2703-10, 2000.
[109] K. Kohli, J. Ali, M. Ansari, and Z. Raheman. Curcumin: A natural antiinflammatory agent. Indian Journal of Pharmacology, 37(3):141-147, 2005.
[110] CM Lebrun. Rosac Cream With Sunscreens (sodium sulfacetamide 10% and sulfur 5%). Skinmed, 3(2):92, 2004.
[111] S. Liao. The medicinal action of androgens and green tea epigallocatechin gallate. Hong Kong Med J, 7(4):369-74, 2001.
[112] A.N. Lin and T. Nakatsui. Salicylic acid revisited. International Journal of Dermatology, 37:335-342, 1998.
[113] T. Maisch, R.M. Szeimies, G. Jori, and C. Abels. Antibacterial photodynamic therapy in dermatology. Photochemical & Photobiological Sciences, 3(10):907-917, 2004.
[114] D. Markin, L. Duek, and I. Berdicevsky. In vitro antimicrobial activity of olive leaves. Antimikrobielle Wirksamkeit von Olivenblattern in vitro. Mycoses, 46(3-4):132-136, 2003.
[115] I. Menzel and H. Holzmann. Reflections on seborrheic scalp eczema and psoriasis capillitii in relation to intestinal mycoses. Z Hautkr, 61(7):451-4, 1986.
[116] R. Muggli. Systemic evening primrose oil improves the biophysical skin parameters of healthy adults. International Journal of Cosmetic Science, 27(4):243, 2005.
[117] J. Noguera, E. Levis, and M. Alguero. Review of the clinical efficacy of flutrimazole gel in the treatment of dandruff and/or seborrheic dermatitis. REVISTA IBEROAMERICANA DE MICOLOGIA, 15:28-32, 1998.
[118] P. Page. Anti-Inflammatory Effects of Third-Generation Antihistamines. Curr Med Res Opin, 20(1):73-81, 2004.
[119] Penn State Milton S. Hershey Medical Center. Seborrheic dermatitis. <http://www.hmc.psu.edu/healthinfo/s/seborrheicdermatitis.htm>, 31 October 2006.
[120] N. Perricone. The Wrinkle Cure: Unlock the Power of Cosmeceuticals for Supple, Youthful Skin. Warner Books, 2001.
[121] C. PIERARD-FRANCHIMONT, V. COFFIN, F. HENRY, I. UHODA, C. BRAHAM, and GE PIERARD. Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations. International journal of cosmetic science, 24(5):249-256, 2002.
[122] Proctor & Gamble Corporation Southeast Asia. Dandruff q & a. <http://www.headandshoulders.com/southeastasia/dandruff/qa.asp#>, 21 December 2006.
[123] D. Rigopoulos, A. Katsambas, C. Antoniou, S. Theocharis, and J. Stratigos. Facial seborrheic dermatitis treated with fluconazole 2 Int J Dermatol, 33(2):136-7, 1994.
[124] R.A. SCHWARTZ, C.A. JANUSZ, and C.K. JANNIGER. Seborrheic Dermatitis: An Overview. Am Fam Physician, 74(1):125-30, 2006.
[125] A. Shemer, N. Nathansohn, B. Kaplan, G. Weiss, N. Newman, and H. Trau. Treatment of scalp seborrheic dermatitis and psoriasis with an ointment of 40% urea and 1% bifonazole. International Journal of Dermatology, 39(7):532-534, 2000.
[126] RC SRIMAL. Turmeric: a brief review of medicinal properties. Fitoterapia(Milano), 68(6):483-493, 1997.
[127] A. Tollesson and A. Frithz. Borage oil, an effective new treatment for infantile seborrhoeic dermatitis. Br J Dermatol, 129(1):95, 1993.
[128] M. Toskic-Radojicic. Testing keratolytic effect of carbamide in various vehicles. Vojnosanit Pregl, 59(4):393-7, 2002.
[129] RG Valia. Etiopathogenesis of seborrheic dermatitis. Indian J Dermatol Venereol Leprol, 72(4):253-5, 2006.
[130] A.E. Varner, W.W. Busse, and R.F. Lemanske Jr. Hypothesis: decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma. Ann Allergy Asthma Immunol, 81(4):347-51, 1998.
[131] Guy Webster. Rxderm archives - accutane-acne. <http://dermatology.cdlib.org/rxderm-archives/accutane-acne>, October 1996.
[132] Guy Webster. Rxderm archives - cyclosporin. <http://dermatology.cdlib.org/rxderm-archives/cyclosporin>, 1996.
[133] LG Zisova. Fluconazole and its place in the treatment of seborrheic dermatitis-new therapeutic possibilities. Folia Med (Plovdiv), 48(1):39-45, 2006.

This bibliography has been generated by bibtex2html 1.85.

Copyright© M.Churchill 2011 -- All Rights Reserved